Subscribe To
Altimmune to present new data on the anti-inflammatory and anti-fibrotic properties of pemvidutide in a late-breaking presentation at the liver meeting® 2023
GAITHERSBURG, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharma...
October 25, 2023, 7:30 am
Apellis pharmaceuticals to host conference call on november 1, 2023, to discuss third quarter 2023 financial results
WALTHAM, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Apellis pharmaceuticals , Inc. (Nasdaq: APLS) today ...
October 25, 2023, 7:00 am
Ani pharmaceuticals to discuss third quarter 2023 financial results on november 8, 2023, at 8:30 a.m. et
BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI pharmaceuticals, Inc. (“ANI” or the “Compa...
October 25, 2023, 6:50 am
Porter's 5 forces suggest that ginkgo is a buy
Ginkgo Bioworks is analyzed based on Porter's Five Forces framework for competitive dynamics. The threat of competition in Ginkgo's R&D discovery busi...
October 25, 2023, 5:49 am
Medivir to report new and updated data from ongoing phase 2a hcc study as part of its q3 report on friday
Webcasted Conference Call on Friday, October 27, 2023 at 14.00 CET STOCKHOLM , Oct. 25, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a ...
October 25, 2023, 2:46 am
Futura medical receives otc sign-off in mexico for ed gel
Futura Medical PLC (AIM:FUM, OTC:FAMDF), a pharmaceutical company specialising in innovative sexual hea...
October 25, 2023, 2:42 am
Collegium pharmaceutical: delivering on promises
Today, we revisit Collegium pharmaceutical, Inc., which has seen a 30% increase in its stock price sinc...
October 24, 2023, 2:59 pm
Why ligand pharmaceuticals (lgnd) is a top value stock for the long-term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre...
October 24, 2023, 11:18 am
Novo nordisk milks the obesity cash cow - how long will it last?
NVO's obesity/diabetes drug, Wegovy/Ozempic, is projected to outperform the best-selling drug of all time, Humira, with an estimated $38.5B in annual ...
October 24, 2023, 9:30 am
Arbutus to report third quarter 2023 financial results and provide corporate update
WARMINSTER, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage...
October 24, 2023, 7:30 am
Marinus pharmaceuticals to provide business update and report third quarter 2023 financial results on november 7, 2023
RADNOR, Pa.--(BUSINESS WIRE)---- $MRNS #MarinusPharma--Marinus pharmaceuticals, Inc. (Nasdaq: MRNS), a ...
October 24, 2023, 7:01 am
Novartis begins new era with profit beat and guidance hike
The Swiss pharmaceutical company says its transition to a pure-play innovative medicines business is no...
October 24, 2023, 5:44 am
Idorsia pharmaceuticals ltd: idorsia announces financial results for the first nine months of 2023 – adapting the company to create sustainable value
Business highlights Transaction withSosei Heptares (hereafter referred as the “Sosei Deal”): Idorsia sold its Asia Pacific (ex-China) operations o...
October 24, 2023, 5:29 am
Amphastar pharmaceuticals (amph) rises as market takes a dip: key facts
In the closing of the recent trading day, Amphastar pharmaceuticals (AMPH) stood at $44.72, denoting a ...
October 23, 2023, 7:33 pm
Vertex pharmaceuticals (vrtx) increases despite market slip: here's what you need to know
In the closing of the recent trading day, Vertex pharmaceuticals (VRTX) stood at $367.66, denoting a +1...
October 23, 2023, 7:33 pm
Lipocine to present at the h.c. wainwright annual nash investor conference
SALT LAKE CITY , Oct. 23, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical compan...
October 23, 2023, 7:00 pm
Canada imports pharmaceutical and medicinal products
Imports (Bop) – pharmaceutical And Medicinal Products in Canada decreased to 2094.30 CAD Million in A...
October 23, 2023, 6:30 pm
Pfizer hopes to avoid scaring investors when it reports 3q results on halloween
Pfizer Inc (NYSE:PFE) is scheduled to report earnings on October 31 before the opening bell, but if past results are any indication, the ...
October 23, 2023, 5:56 pm
Roche settles us patent lawsuit against biogen over blockbuster arthritis drug
Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over i...
October 23, 2023, 3:28 pm
Ardelyx shares positive data on symptom response during treatment with ibsrela® (tenapanor) for ibs-c and hosts ibs-c product theater at acg 2023
WALTHAM, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical co...
October 23, 2023, 12:07 pm